menu
Global Preventive vaccine Market Headed for Growth and Expansion by 2030
Global Preventive vaccine Market Headed for Growth and Expansion by 2030
More than 200 preventive vaccines, developed by both industry and non-industry players, are being evaluated in clinical stages of development, claims Roots Analysis

Technicaladvances, especially in the field of biotechnology, have led to the developmentof several next generation preventive vaccines, including recombinant vaccines,viral vector based vaccines and DNA vaccines, which have been demonstrated toelicit powerful immune responses, resulting in the development of immunologicalmemory.

TheUSD 94 billion (by 2030) financial opportunity within the global preventivevaccine market has been analyzed across the following segments:

Routeof Administration

·       Intramuscular

·       Subcutaneous

·       Oral

·       Intravenous

·       Others

Typeof Vaccine

·       Pneumococcal Conjugate Vaccine

·       Human Papilloma Virus Vaccine

·       Rotavirus Vaccine

·       Influenza Vaccine

·       MMR Vaccine

·       Tetanus and Diphtheria Booster Vaccine

·       Varicella Vaccine

·       DTaP-Hib-IPV Vaccine

·       DTaP-HepB-Hib-IPV Vaccine

·       Others

Typeof Vaccine API

·       Live, Attenuated Vaccine

·       Inactivated Vaccine

·       Conjugate Vaccine

·       Subunit Vaccine

·       Toxoid Vaccine

·       Others

TargetPatient Population

·       Pediatric Patients

·       Adult

KeyPlayers

·       GlaxoSmithKline

·       Merck

·       Sanofi Pasteur

·       Pfizer

·       Emergent BioSolutions

·       CSL

·       Others

KeyGeographical Regions

·       North America

·       Europe

·       Asia Pacific

·       Rest of the World

TheGlobal PreventiveVaccines Market, 2020-2030 report features the following companies, whichwe identified to be key players in this domain:

·       Bio Farma

·       Emergent BioSolutions

·       GC Pharma

·       GlaxoSmithKline

·       Janssen

·       Merck

·       Novavax

·       Pfizer

·       Sanofi Pasteur

·       Valneva

Tableof Contents

1. Preface

2. Executive Summary

3. Introduction

4.  MarketLandscape

5. Company Competitiveness Analysis

6. Company Profiles

7. Clinical Trial Analysis

8. Ongoing Vaccine Development Initiatives for ComplexConditions

9. Funding and Investment Analysis

10. Market Sizing and Opportunity Analysis

11. Case-in-Point: Contract Manufacturing of Vaccines

12. Concluding Remarks

13. Executive Insights

14. Appendix 1: Tabulated Data

15. Appendix 2: List of Companies and Organizations

Formore information, please click on the following link:

https://www.rootsanalysis.com/reports/view_document/preventive-vaccines/318.html    

AboutRoots Analysis

RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com

ContactInformation

RootsAnalysis Private Limited

GauravChaudhary

+1(415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com